|
Biotech Showcase 2025, an exciting and content-packed programme it dives deep into the future of biotechnology and healthcare innovation, will once again serve as the premier destination for global biopharma leaders to connect and advance innovation during JP Morgan Healthcare Week, which will take place from January 13 to 15, 2025, in San Francisco, and virtually from January 21-22, 2025.
The event will bring together more than 3,200 professionals, including over 1,200 investors, from across the life sciences industry.
As the largest and most influential investor conference for private and micro-mid-cap biotechnology companies, Biotech Showcase offers unique opportunities for companies to showcase cutting-edge innovations and meet one-to-one with investors and biopharmaceutical executives. The conference is seamlessly integrated with the TechBio and Seed Showcases, offering unmatched opportunities to engage with the full spectrum of life science innovation.
In-person events will include expert-led panels and company presentations addressing the industry’s most pressing challenges. Attendees will benefit from one-to-one meetings, face-to-face networking sessions, and extensive on-demand content, including recordings of sessions and workshops, to ensure valuable connections during and after the event.
“Biotech Showcase has become the cornerstone for connecting leading biotech companies with the investors and partners who can accelerate the next generation of therapeutic breakthroughs. We’re excited to welcome both returning and new attendees to engage in a robust agenda of sessions, workshops, and one-to-one meetings,” said Sara Jane Demy, founder and CEO of Demy-Colton.
The 2025 agenda will feature discussions on trending topics, including:
The battle against cancer: The Armamentarium keeps expanding 2025.
Cell & gene state of the industry briefing: Expediting the development of cell and gene therapy.
What is TechBio and what impact will it have on therapeutic development?
Healthcare access & equity: Leading to better healthcare for all.
The new policy landscape: Now that the election is behind us, where do we go from here?
Financing the biotech sector: After a difficult few years, is there finally a reason for optimism?
Tina Elder, global managing, director, EBD Group US, added, “Biotech Showcase has proven itself as the go-to event for facilitating meaningful connections that drive investments and partnerships. With more than 1,200 investors, Biotech Showcase provides unparalleled access to global opportunities. The partneringONE platform enhances the experience, allowing for seamless scheduling and interaction between investors, companies, and thought leaders.”
With more than 325 presenting companies and a projected 6,000+ one-to-one meetings, Biotech Showcase is set to deliver another record-breaking year in terms of networking and deal-making opportunities.
Registration provides access to the full conference experience, including exclusive content and specialized events such as TechBio Showcase and Seed Showcase. Virtual attendees will benefit from partnering privileges in addition to on-demand access to company showcases and session recordings.
For information about registering for Biotech Showcase or to apply to present or sponsor, please visit https://informaconnect.com/biotech-showcase/
|